MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder Cancer
-
Published:2023-12-20
Issue:1
Volume:25
Page:88
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Qureshi Touseef Ahmad12ORCID, Chen Xingyu23ORCID, Xie Yibin1, Murakami Kaoru45ORCID, Sakatani Toru4, Kita Yuki5, Kobayashi Takashi5ORCID, Miyake Makito6ORCID, Knott Simon R. V.24, Li Debiao1, Rosser Charles J.34ORCID, Furuya Hideki24ORCID
Affiliation:
1. Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA 2. Department of Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA 3. Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA 4. Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA 5. Department of Urology, Kyoto University, Kyoto 606-8507, Japan 6. Department of Urology, Nara Medical University, Kashihara 634-8522, Japan
Abstract
Accurate staging of bladder cancer assists in identifying optimal treatment (e.g., transurethral resection vs. radical cystectomy vs. bladder preservation). However, currently, about one-third of patients are over-staged and one-third are under-staged. There is a pressing need for a more accurate staging modality to evaluate patients with bladder cancer to assist clinical decision-making. We hypothesize that MRI/RNA-seq-based radiogenomics and artificial intelligence can more accurately stage bladder cancer. A total of 40 magnetic resonance imaging (MRI) and matched formalin-fixed paraffin-embedded (FFPE) tissues were available for analysis. Twenty-eight (28) MRI and their matched FFPE tissues were available for training analysis, and 12 matched MRI and FFPE tissues were used for validation. FFPE samples were subjected to bulk RNA-seq, followed by bioinformatics analysis. In the radiomics, several hundred image-based features from bladder tumors in MRI were extracted and analyzed. Overall, the model obtained mean sensitivity, specificity, and accuracy of 94%, 88%, and 92%, respectively, in differentiating intra- vs. extra-bladder cancer. The proposed model demonstrated improvement in the three matrices by 17%, 33%, and 25% and 17%, 16%, and 17% as compared to the genetic- and radiomic-based models alone, respectively. The radiogenomics of bladder cancer provides insight into discriminative features capable of more accurately staging bladder cancer. Additional studies are underway.
Funder
Cedars-Sinai Cancer Developmental Funds
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference44 articles.
1. Cancer statistics, 2023;Siegel;CA Cancer J. Clin.,2023 2. Howlader, N., Noone, A.M., Krapcho, M., Garshell, J., Neyman, N., Altekruse, S.F., Kosary, C.L., Yu, M., Ruhl, J., and Tatalovich, Z. (2014, May 01). SEER Cancer Statistics Review, 1975–2010, Available online: http://seer.cancer.gov/csr/1975_2010/. 3. A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group;Brausi;J. Urol.,2011 4. Treatment of muscle-invasive and metastatic bladder cancer: Update of the EAU guidelines;Stenzl;Eur. Urol.,2011 5. Metastatic bladder cancer: Anything new?;Calabro;Curr. Opin. Support. Palliat. Care,2012
|
|